A novel UNC93B1 gain-of-function mutation leads to TLR7 and TLR8 hyperactivation and systemic lupus erythematosus

Xu Han,RuoRan Wang,Seza Ozen,Qintao Wang,Wei Dong,Yi Zeng,Ouyuan Xu,Seher Şenar,Li Guo,Ying Gu,Huanming Yang,Xiaomin Yu,Panfeng Tao,Qing Zhou

DOI: https://doi.org/10.1101/2024.09.11.24313360

2024-09-13

Abstract:Dysfunctions in nucleic acid-sensing Toll-like receptors (TLRs) disrupt nucleic acid tolerance, leading to systemic lupus erythematosus (SLE). Here, we report a novel homozygous gain-of-function p.R95L mutation in the TLR chaperone protein UNC93B1 in an SLE patient. Bulk and single-cell transcriptional analysis of the patient's peripheral blood mononuclear cells (PBMCs) revealed significantly elevated inflammation in T cells and myeloid cells due to enhanced dendritic cells function. The UNC93B1 R95L mutation leads to hyperactivation of TLR7/8, but not TLR3/9, upon stimulation with specific agonists in vitro. Transgenic Unc93b1R95L/R95L mice develop inflammatory and autoimmune phenotypes, and the upregulation of inflammatory signaling differs among organs, with a specific contribution of malfunctioned T cells and B cells. In human and mouse cell lines, the UNC93B1 R95L mutation promotes TLR7/8 signaling by enhancing its binding to ssRNA, without affecting TLR7/8 translocation. Overall, our results elucidate the pathology of organs and the immunological profiles of immune cell populations in the development of SLE caused by the UNC93B1 R95L mutation through the TLR7/8 axis.

What problem does this paper attempt to address?

The paper aims to address the issue of immune dysregulation caused by UNC93B1 gene mutations in systemic lupus erythematosus (SLE). Specifically, the study identifies a novel gain-of-function mutation in the UNC93B1 gene (p.R95L), which leads to the overactivation of TLR7 and TLR8 in patients. Through a series of experiments, including in vitro cell experiments, transgenic mouse models, and single-cell transcriptome analysis, the research reveals how the UNC93B1 R95L mutation induces SLE-related organ pathological changes and the immunological characteristics of immune cell populations via the TLR7/8 axis. This discovery helps to understand the pathogenesis of SLE and provides potential targets for future therapeutic strategies.